AVBP vs. SMH
AVBP (ArriVent BioPharma Inc. Common Stock) is a stock, while SMH (VanEck Semiconductor ETF) is Semiconductors fund tracking the MVIS US Listed Semiconductor 25 Index. Over the past year, AVBP returned 28.81% vs 157.20% for SMH. At a 0.19 correlation, their price movements are largely independent.
Performance
AVBP vs. SMH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AVBP achieves a 48.01% return, which is significantly lower than SMH's 77.13% return.
AVBP
- 1D
- -0.47%
- 1M
- -1.97%
- YTD
- 48.01%
- 6M
- 30.16%
- 1Y
- 28.81%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
SMH
- 1D
- 0.90%
- 1M
- 25.87%
- YTD
- 77.13%
- 6M
- 75.61%
- 1Y
- 157.20%
- 3Y*
- 64.17%
- 5Y*
- 39.21%
- 10Y*
- 37.68%
AVBP vs. SMH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
AVBP ArriVent BioPharma Inc. Common Stock | 48.01% | -24.47% | 33.20% |
SMH VanEck Semiconductor ETF | 77.13% | 49.17% | 29.20% |
Correlation
The correlation between AVBP and SMH is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Jan 29, 2024 | 0.19 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AVBP vs. SMH — Risk / Return Rank
AVBP
SMH
AVBP vs. SMH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ArriVent BioPharma Inc. Common Stock (AVBP) and VanEck Semiconductor ETF (SMH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AVBP | SMH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -4.67 | ||
| Sortino ratioReturn per unit of downside risk | -4.04 | ||
| Omega ratioGain probability vs. loss probability | 1.13 | 1.72 | -0.59 |
| Calmar ratioReturn relative to maximum drawdown | 0.87 | 10.59 | -9.72 |
| Martin ratioReturn relative to average drawdown | 1.68 | 40.63 | -38.94 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| AVBP | SMH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.52 | 5.19 | -4.67 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 1.13 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 1.16 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.34 | 0.34 | 0.00 |
Drawdowns
AVBP vs. SMH - Drawdown Comparison
The maximum AVBP drawdown since its inception was -54.25%, smaller than the maximum SMH drawdown of -84.96%. Use the drawdown chart below to compare losses from any high point for AVBP and SMH.
Loading charts...
Drawdown Indicators
| AVBP | SMH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -54.25% | -84.96% | +30.71% |
Max Drawdown (1Y)Largest decline over 1 year | -33.32% | -14.93% | -18.39% |
Max Drawdown (3Y)Largest decline over 3 years | — | -35.74% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -45.30% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -45.30% | — |
Current DrawdownCurrent decline from peak | -16.42% | 0.00% | -16.42% |
Average DrawdownAverage peak-to-trough decline | -27.69% | -41.09% | +13.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.15% | 3.89% | +13.26% |
Volatility
AVBP vs. SMH - Volatility Comparison
ArriVent BioPharma Inc. Common Stock (AVBP) has a higher volatility of 15.57% compared to VanEck Semiconductor ETF (SMH) at 11.47%. This indicates that AVBP's price experiences larger fluctuations and is considered to be riskier than SMH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AVBP | SMH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.57% | 11.47% | +4.10% |
Volatility (6M)Calculated over the trailing 6-month period | 41.45% | 24.29% | +17.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 56.09% | 30.56% | +25.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 54.27% | 35.01% | +19.26% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 54.27% | 32.57% | +21.70% |
Dividends
AVBP vs. SMH - Dividend Comparison
AVBP has not paid dividends to shareholders, while SMH's dividend yield for the trailing twelve months is around 0.17%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AVBP ArriVent BioPharma Inc. Common Stock | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SMH VanEck Semiconductor ETF | 0.17% | 0.31% | 0.44% | 0.60% | 1.18% | 0.51% | 0.69% | 1.50% | 1.88% | 1.43% | 0.80% | 2.14% |
Frequently Asked Questions
AVBP and SMH have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AVBP has higher volatility (15.57%) compared to SMH (11.47%). In terms of maximum drawdown, AVBP dropped -54.25% vs SMH's -84.96%.
SMH currently has the higher Sharpe Ratio (5.19 vs 0.52), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AVBP and SMH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer